196 related articles for article (PubMed ID: 15590661)
1. Endoproteolytic cleavage of human thyroperoxidase: role of the propeptide in the protein folding process.
Le Fourn V; Ferrand M; Franc JL
J Biol Chem; 2005 Feb; 280(6):4568-77. PubMed ID: 15590661
[TBL] [Abstract][Full Text] [Related]
2. Calnexin and calreticulin binding to human thyroperoxidase is required for its first folding step(s) but is not sufficient to promote efficient cell surface expression.
Fayadat L; Siffroi-Fernandez S; Lanet J; Franc JL
Endocrinology; 2000 Mar; 141(3):959-66. PubMed ID: 10698171
[TBL] [Abstract][Full Text] [Related]
3. Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic reticulum. Its N-glycans are required for folding and intracellular trafficking.
Fayadat L; Niccoli-Sire P; Lanet J; Franc JL
Endocrinology; 1998 Oct; 139(10):4277-85. PubMed ID: 9751510
[TBL] [Abstract][Full Text] [Related]
4. Kinetic characterization of human thyroperoxidase. Normal and pathological enzyme expression in Baculovirus system: a molecular model of functional expression.
Belforte FS; Targovnik AM; González-Lebrero RM; Osorio Larroche C; Citterio CE; González-Sarmiento R; Miranda MV; Targovnik HM; Rivolta CM
Mol Cell Endocrinol; 2015 Mar; 404():9-15. PubMed ID: 25576858
[TBL] [Abstract][Full Text] [Related]
5. Effects of deglycosylation of human thyroperoxidase on its enzymatic activity and immunoreactivity.
Giraud A; Franc JL; Long Y; Ruf J
J Endocrinol; 1992 Feb; 132(2):317-23. PubMed ID: 1371804
[TBL] [Abstract][Full Text] [Related]
6. Competition between calnexin and BiP in the endoplasmic reticulum can lead to the folding or degradation of human thyroperoxidase.
Le Fourn V; Siffroi-Fernandez S; Ferrand M; Franc JL
Biochemistry; 2006 Jun; 45(23):7380-8. PubMed ID: 16752927
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate moieties in recombinant human thyroid peroxidase: role in recognition by antithyroid peroxidase antibodies in Hashimoto's thyroiditis.
Foti D; Rapoport B
Endocrinology; 1990 Jun; 126(6):2983-8. PubMed ID: 1693564
[TBL] [Abstract][Full Text] [Related]
8. Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein.
Fayadat L; Siffroi-Fernandez S; Lanet J; Franc JL
J Biol Chem; 2000 May; 275(21):15948-54. PubMed ID: 10748076
[TBL] [Abstract][Full Text] [Related]
9. Cell type-dependent differences in thyroid peroxidase cell surface expression.
Zhang X; Arvan P
J Biol Chem; 2000 Oct; 275(41):31946-53. PubMed ID: 10924504
[TBL] [Abstract][Full Text] [Related]
10. Role of heme in intracellular trafficking of thyroperoxidase and involvement of H2O2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding.
Fayadat L; Niccoli-Sire P; Lanet J; Franc JL
J Biol Chem; 1999 Apr; 274(15):10533-8. PubMed ID: 10187846
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis, distinct post-translational modifications, and functional characterization of lymphoma proprotein convertase.
van de Loo JW; Creemers JW; Bright NA; Young BD; Roebroek AJ; Van de Ven WJ
J Biol Chem; 1997 Oct; 272(43):27116-23. PubMed ID: 9341152
[TBL] [Abstract][Full Text] [Related]
12. Generation of a biologically active, secreted form of human thyroid peroxidase by site-directed mutagenesis.
Foti D; Kaufman KD; Chazenbalk GD; Rapoport B
Mol Endocrinol; 1990 May; 4(5):786-91. PubMed ID: 2274058
[TBL] [Abstract][Full Text] [Related]
13. Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies.
Bresson D; Pugnière M; Roquet F; Rebuffat SA; N-Guyen B; Cerutti M; Guo J; McLachlan SM; Rapoport B; Estienne V; Ruf J; Chardès T; Péraldi-Roux S
J Biol Chem; 2004 Sep; 279(37):39058-67. PubMed ID: 15150267
[TBL] [Abstract][Full Text] [Related]
14. Targeting of the dual oxidase 2 N-terminal region to the plasma membrane.
Morand S; Agnandji D; Noel-Hudson MS; Nicolas V; Buisson S; Macon-Lemaitre L; Gnidehou S; Kaniewski J; Ohayon R; Virion A; Dupuy C
J Biol Chem; 2004 Jul; 279(29):30244-51. PubMed ID: 15150274
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase.
Rozenfeld R; Muller L; El Messari S; Llorens-Cortes C
J Biol Chem; 2004 Oct; 279(41):43285-95. PubMed ID: 15263000
[TBL] [Abstract][Full Text] [Related]
16. Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum.
Creemers JW; Vey M; Schäfer W; Ayoubi TA; Roebroek AJ; Klenk HD; Garten W; Van de Ven WJ
J Biol Chem; 1995 Feb; 270(6):2695-702. PubMed ID: 7852339
[TBL] [Abstract][Full Text] [Related]
17. The prosequence of human lactase-phlorizin hydrolase modulates the folding of the mature enzyme.
Jacob R; Peters K; Naim HY
J Biol Chem; 2002 Mar; 277(10):8217-25. PubMed ID: 11751874
[TBL] [Abstract][Full Text] [Related]
18. Paired basic/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network.
Leighton M; Kadler KE
J Biol Chem; 2003 May; 278(20):18478-84. PubMed ID: 12637569
[TBL] [Abstract][Full Text] [Related]
19. Increasing diversity of human thyroperoxidase generated by alternative splicing. Characterized by molecular cloning of new transcripts with single- and multispliced mRNAs.
Ferrand M; Le Fourn V; Franc JL
J Biol Chem; 2003 Feb; 278(6):3793-800. PubMed ID: 12454013
[TBL] [Abstract][Full Text] [Related]
20. A plasminogen-like protease in thyroid rough microsomes degrades thyroperoxidase and thyroglobulin.
Giraud A; Lejeune PJ; Barbaria J; Mallet B
Endocrinology; 2007 Jun; 148(6):2886-93. PubMed ID: 17332062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
